ArticleCancer cell2010

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.

Ke Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.